Rare diseases
Investigational molecules
Locations
Back to Germany324 clinical trials in Goettingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effects of VRDN-003 for Patients with Active Thyroid Eye Disease
GermanyStudy comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis
GermanyStudy on Mavacamten for Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
GermanyStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination
GermanyStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
GermanyStudy of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome
GermanyStudy on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients
GermanyA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
GermanyA Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome
GermanyA Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies
GermanyA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
GermanyA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on acute cerebral ischemic stroke treatment and groundbreaking studies in Alzheimer's Disease management, evaluating novel therapeutic approaches for improving patient outcomes.
Clinical trials examining the safety and efficacy of targeted therapies for acute neurological conditions.
Comprehensive studies in various cancer types, including lymphoma and lung cancer, with particular focus on targeted therapies and innovative treatment combinations.
Evaluating novel therapeutic approaches for both rare and common cancer types.
Advanced research in eye disorders, particularly focusing on thyroid eye disease and geographic atrophy, exploring new treatment modalities and therapeutic antibodies.
Investigating breakthrough treatments for both rare and common eye conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
